Aspen-Pfizer favorable court decision to be challenged by CADE at appellate level
The Brazilian antitrust agency will challenge, at an appellate federal court, a decision that would allow drugmakers Pfizer and Aspen Pharmacare to close their deal during the regulator’s temporary ban, a...To view the full article, register now.
Already a subscriber? Click here to view full article